Pagamon launched an assessment for potential further acquisitions in the Life Sciences sector
Project outline
- The client is a public listed biotech company. He wishes to acquire certain activities in vaccines
- The client needs a consulting support to realize a first assessment of the targeted activities
Project approach
- Search for qualitative and quantitative information on the targeted vaccines for 5 antigens
- Development of sales forecast models over the next 10 years (volume, value, price), including long-term trends
- Insiders interviews for gathering qualitative and quantitative data validating our models and assumptions
- Costs estimates: COGS, M&S, A&P, PV, RA, Medical affaires, Supply Chain/Distribution/Customer service costs
- Calculation of NPV and the residual value for each product for the next 20 years
- Acquisition or distribution recommendations covering products
Results
- Recommendations for the Executive Committee regarding acquisitions
- Evaluation report for each opportunity: preparatory work to term sheets raising
- P&L model for each product